Weber, Martin S., Jacqueline A. Nicholas, and Michael R. Yeaman. "Balancing Potential Benefits and Risks of Bruton Tyrosine Kinase Inhibitor Therapies in Multiple Sclerosis During the COVID-19 Pandemic." Neurology - Neuroimmunology Neuroinflammation 8.6 (2021): e1067. Web. 04 Oct. 2023.

Citation Manager Formats